Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr964 Inhibitors

Olr964 inhibitors represent a class of chemical compounds that interact specifically with the olfactory receptor Olr964, a G-protein coupled receptor involved in the detection of odorants. These inhibitors function by binding to the active site or an allosteric site on the Olr964 receptor, thereby modulating its activity. The structure of Olr964 inhibitors is typically characterized by a diverse array of functional groups that enhance their binding affinity and specificity to the receptor. Common structural motifs include aromatic rings, heterocycles, and various substituents that can interact with amino acid residues within the binding pocket. These structural elements are designed to optimize van der Waals forces, hydrogen bonding, and π-π interactions, ensuring a robust and selective inhibition of the Olr964 receptor.

The synthesis of Olr964 inhibitors often involves multi-step organic synthesis, employing strategies such as palladium-catalyzed coupling reactions, nucleophilic substitutions, and cyclization reactions to construct the core structure. Advanced techniques such as high-throughput screening and computational modeling are utilized to identify potential inhibitors and refine their chemical properties. Once synthesized, these inhibitors are subject to rigorous evaluation through biochemical assays, where their ability to inhibit Olr964 is quantified using metrics like IC50 values. The study of Olr964 inhibitors not only advances the understanding of olfactory receptor functionality but also provides insights into receptor-ligand interactions at a molecular level. Through detailed investigation of these inhibitors, researchers can explore the intricate mechanisms of olfactory signal transduction and receptor dynamics, contributing to the broader field of chemosensory science.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL tyrosine kinase, potentially impacting signaling pathways associated with Olr964.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR inhibitor, could modulate signaling pathways that intersect with Olr964's activity.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Inhibits MEK, potentially affecting MAPK/ERK pathway which might be linked to Olr964.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

Targets MEK1/2, potentially impacting signaling cascades relevant to Olr964.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, might influence pathways linked with Olr964.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, likely affecting signaling networks relevant to Olr964.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Targets VEGFR, PDGFR, and c-Kit, potentially modulating signaling pathways related to Olr964.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Inhibits VEGFR, FGFR, PDGFR, RET, and KIT, likely affecting diverse signaling networks linked to Olr964.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Multi-kinase inhibitor, could influence pathways that intersect with Olr964's function.

Cobimetinib

934660-93-2sc-507421
5 mg
$270.00
(0)

Inhibits MEK, potentially affecting MAPK/ERK pathway which might be relevant to Olr964.